20-F/A: ASR Nederland 2025 Annual Report Amendment Reveals Mixed Financials

Aegon Ltd. files an amendment to its 2025 annual report, incorporating ASR Nederland N.V.'s audited financials which show a significant decrease in net result despite strong solvency and strategic acquisitions.

Summary

• ASR Nederland N.V. (ASR) reported a net result of €565 million for 2025, a significant decrease from €956 million in 2024.
• Insurance contract revenue increased to €10,324 million in 2025 from €9,601 million in 2024.
• The operating result, an alternative performance measure, increased to €1,637 million in 2025 from €1,463 million in 2024.
• The Solvency II ratio improved to 218% in 2025 from 198% in 2024, partly due to the transition to the Partial Internal Model (PIM) methodology for a.s.r. life (+12%-points).
• ASR completed the acquisition of the remaining 55% interest in HumanTouch Holding B.V. for €108 million, reinforcing its position in occupational health and reintegration services.
• A voluntary change in accounting policy for individual disability contracts was implemented retrospectively, reclassifying incurred claims to remaining coverage, aiming to reduce complexity and improve relevance.
• Total comprehensive income decreased to €793 million in 2025 from €1,232 million in 2024.
• Basic earnings per share decreased to €2.30 in 2025 from €4.24 in 2024.
• Total assets increased to €142,151 million in 2025 from €138,582 million in 2024, while total equity increased to €10,124 million from €9,888 million.
• Cash and cash equivalents decreased to €2,709 million in 2025 from €4,194 million in 2024.
• Subordinated liabilities decreased to €1,503 million in 2025 from €2,007 million in 2024, following a tender offer and redemption.
• ASR issued €500 million perpetual subordinated restricted Tier 1 capital securities in April 2025.
• ASR repurchased 2,404 thousand shares for €125 million under a share buyback program, 300 thousand shares for €17 million for employee plans, and 1,875 thousand shares for €105 million from Aegon Ltd.
• A total dividend of €3.41 per share is proposed for 2025, an increase from €3.12 per share in 2024.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed report. While ASR Nederland demonstrates strong capital management with an improved Solvency II ratio and strategic growth through acquisitions, the substantial decline in net result and negative investment performance are notable concerns. The increase in operating result suggests underlying business strength, but overall profitability was significantly impacted by market movements.

Positives

• The Solvency II ratio increased significantly to 218% in 2025 from 198% in 2024, comfortably above the internal requirement of 120% and management threshold of 160%.
• The operating result increased to €1,637 million in 2025 from €1,463 million in 2024, indicating strong underlying business performance.
• ASR successfully completed the acquisition of the remaining 55% interest in HumanTouch Holding B.V. for €108 million, strengthening its position in occupational health and reintegration services.
• A total dividend of €3.41 per share is proposed for 2025, an increase from €3.12 per share in 2024, reflecting a progressive dividend policy.
• ASR successfully issued €500 million in Subordinated Restricted Tier 1 securities, enhancing its capital structure.
• Standard & Poor's (S&P) upgraded ratings for a.s.r. and its insurance entities to A(Issuer Credit Rating) and A+ (Insurer Financial Strength Rating) with a stable outlook, reflecting a strong financial risk profile and solid capital position.
• The implementation of the Partial Internal Model (PIM) for a.s.r. life contributed +12%-points to the Solvency II ratio and optimized risk capital calculations.
• Insurance contract revenue increased to €10,324 million in 2025 from €9,601 million in 2024.
• Premiums received in the Life segment were positively impacted by pension buy-outs, amounting to €2.8 billion.

Negatives

• Net result decreased significantly to €565 million in 2025 from €956 million in 2024.
• The investment and finance result decreased substantially to €5 million in 2025 from €842 million in 2024, primarily due to negative fair value gains and losses.
• Net fair value gains (and losses) turned negative at -€4,093 million in 2025 compared to positive €4,459 million in 2024, mainly due to movements in interest rates and revaluations.
• Basic earnings per ordinary share decreased to €2.30 in 2025 from €4.24 in 2024.
• Cash and cash equivalents decreased to €2,709 million in 2025 from €4,194 million in 2024.
• Cash collateral paid increased by €2.4 billion, indicating higher derivative liabilities due to rising interest rates.
• The Disability business experienced adverse claims development due to elevated incidence rates, especially related to psychological absenteeism and long COVID, leading to a pre-tax income loss of €104 million.
• Deferred tax assets decreased to €36 million in 2025 from €101 million in 2024, mainly caused by changes to the tax base of technical provisions and related assets.
• The provision for unit-linked product claims, while decreased, still amounts to €53 million, indicating ongoing settlement obligations.

Risks

• Underwriting risk: The risk that future insurance claims and benefits cannot be covered by premium and/or investment income, or that insurance liabilities are insufficient due to inaccurate assumptions (mortality, longevity, disability-morbidity, lapse, expense, catastrophe).
• Market risk: The risk of changes in values caused by market prices or volatility of market prices differing from expected values, or losses due to unexpected failure to pay or credit rating downgrade of counterparties and debtors (mismatch, equity, property, currency, spread, concentration).
• Liquidity risk: The risk that ASR is unable to meet its financial obligations to policyholders and other creditors when they become due and payable, at a reasonable cost and in a timely manner, especially from illiquid assets like private loans, mortgages, and real estate.
• Operational risk: The risk of losses caused by weak or failing internal procedures, weaknesses in personnel actions, weaknesses in systems, or external events (process, information technology, project, reporting & model integrity).
• Strategic risk: The risk of ASR or its business lines failing to achieve objectives due to incorrect decision-making, incorrect implementation, or an inadequate response to changes in the environment (macro-economic, geopolitical instability, climate change and energy transition, cyber and information security, artificial intelligence, regulation, biodiversity, social tensions, pandemics).
• Unit-linked products: Residual risk from potential future claims and reputational impact despite comprehensive settlements with consumer protection organizations.
• Optas litigation: A pending appeal procedure related to alleged rights to indexation of pension rights, with no assurances regarding its material impact on ASR's business, results of operations, and financial position.
• Concentration risk: Concentration of exposures to the same counterparty, region, or country, although ASR non-life has no material exposure outside the Netherlands.
• Cyber threats: Significant dependence on automated systems makes cyber threats a continuous concern, addressed in business continuity management.
• Model risk: The risk of errors and misinterpretations in models used for risk, capital, pricing, and valuation purposes.

Future Outlook

ASR expects the impact of IFRS 18, effective January 1, 2027, to be limited to presentation and disclosure changes, with no change expected to the financial results. The company plans to continue its program to achieve a lower cost level in 2026, driven by the integration of Aegon NL entities. Remaining unit-linked compensation agreements are scheduled for settlement in the first half of 2026. The acquisition of Bovemij N.V.'s insurance activities is expected to be completed in the second half of 2026, pending regulatory approvals. ASR announced a new share buyback of €190 million, starting February 18, 2026, and expected to be completed before May 19, 2026. The company maintains a progressive dividend policy, aiming for mid to high single-digit annual growth until (and including) 2026. ASR will continue to monitor developments related to Pillar 2 legislation and its applicability.

Management Comments

• Paul van Ammelrooij, Director Group Finance: "Financial health and cost-efficiency are more than metrics; they form the foundation for growth and responsible entrepreneurship, ensuring long-term value creation."
• Lard Friese, Chief Executive Officer of Aegon Ltd., certified that the Amendment No. 1 to the Annual Report on Form 20-F does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
• Duncan Russell, Chief Financial Officer of Aegon Ltd., certified that the Amendment No. 1 to the Annual Report on Form 20-F does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Industry Context

StockSavvy.ai notes that ASR Nederland's strong Solvency II ratio and strategic acquisitions, particularly in occupational health services (HumanTouch Holding) and the mobility insurance sector (Bovemij), reflect a broader trend in the European insurance industry towards consolidation and diversification into adjacent service areas to drive growth and enhance value propositions. The decrease in net result, largely driven by negative fair value adjustments on investments, highlights the sensitivity of financial performance to market interest rate movements, a common challenge for insurers managing large investment portfolios in volatile economic environments. The ongoing adjustments to IFRS 17 and Solvency II frameworks, including the adoption of the Partial Internal Model, demonstrate the industry's continuous adaptation to evolving regulatory landscapes aimed at enhancing transparency and risk management.

Comparison to Industry Standards

• ASR Nederland's Solvency II ratio of 218% (2025) is comfortably above its internal minimum of 120% and management threshold of 160%, indicating a robust capital position compared to regulatory and internal benchmarks.
• The S&P rating upgrade to A(Issuer Credit Rating) and A+ (Insurer Financial Strength Rating) with a stable outlook for ASR and its insurance entities positions it favorably against industry peers, reflecting strong financial and business risk profiles.
• The voluntary change in accounting policy for individual disability contracts to Liability for Remaining Coverage aligns with "recently emerged market practice, enhancing comparability and consistency across the industry."
• The update of the mortgage spread model in line with "industry standards that were published in 2025" for mortgage valuation indicates adherence to evolving best practices.
• The risk adjustment for a group of insurance contracts is determined using a Cost of Capital (CoC) method similar to the risk margin used for reporting under the Solvency II framework, demonstrating alignment with established prudential reporting frameworks.

Corporate Governance

Legal Proceedings

• Unit-linked products (beleggingsverzekeringen): Comprehensive settlement with five consumer protection organizations finalized in February 2025, substantially reducing outstanding legal exposure. A leniency scheme for non-affiliated customers closed on June 1, 2025. Residual risk from future claims and reputational impact remains possible.
• Optas: An appeal procedure is pending related to alleged rights to indexation of pension rights, following a District Court ruling that denied the claims. Aegon life does not expect a material impact, but no assurances can be given.

Related Party Transactions

• ASR paid €200 million in dividends to Aegon Ltd. in 2025 (compared to €188 million in 2024).
• ASR received €55 million from Aegon Ltd. for tax settlement for the years 2022 and 2023.
• ASR repurchased 1,875 thousand shares for €105 million from Aegon Ltd. in September 2025, reducing Aegon Ltd.'s shareholding from 29.96% to approximately 24%.
• Transitional service agreements (TSAs) are in place with Aegon Ltd. group for services like IT infrastructure and asset management during the integration of Aegon entities.
• Mortgage loans to Management Board members amounted to €2,529 thousand in 2025 (€2,282 thousand in 2024), issued at arms-length conditions, with one member receiving an interest-rate discount.
• The Defined Benefit (DB) obligation of former Aegon NL classifies as a multiple-employer contract, with Aegon Ltd. recovering 29% of the guarantee premium.
• Loans to group companies amounted to €47 million in 2025 (€124 million in 2024).
• Debts to group companies amounted to €177 million in 2025 (€208 million in 2024).

Stakeholder Impact

• Shareholders: Benefit from a progressive dividend policy and share buybacks, but face lower net result and earnings per share. The S&P rating upgrade is positive for investor confidence.
• Employees: The acquisition of HumanTouch Holding added 1,428 FTEs, contributing to workforce growth. Employees participate in an employee share purchase plan. Changes in pension plans (DC for new employees, DB for former employees) and restructuring provisions related to the Aegon NL integration impact employee benefits and job security.
• Customers: Benefit from the finalization of unit-linked settlements, reducing legal exposure. ASR maintains a minimal risk appetite for customer risks, focusing on service and satisfaction. The planned Bovemij acquisition aims to continue advisory and distribution services for mobility sector customers.
• Creditors: A strong Solvency II ratio and S&P rating upgrade indicate robust financial health, enhancing confidence for creditors. Subordinated liabilities are actively managed through issuance and redemption.
• Society: ASR emphasizes sustainability ambitions, ethical conduct, and regulatory compliance. Its tax policy focuses on compliance and responsible tax management, viewing tax as a driver of social cohesion and sustainable growth.

Next Steps

• Settlement of remaining unit-linked compensation agreements in the first half of 2026.
• Continuation of the program to achieve a lower cost level due to the integration of Aegon NL entities in 2026.
• Annual General Meeting (AGM) of Shareholders on May 20, 2026, for adoption of 2025 financial statements and approval to cancel repurchased shares.
• Completion of the acquisition of Bovemij N.V.'s insurance activities in the second half of 2026, subject to regulatory approvals.
• Share buyback program of €190 million to be completed before May 19, 2026.
• Monitoring of Pillar 2 legislation developments and applicability of exemptions.
• Further embedding of risk management and internal control system enhancements in 2026.
• IFRS 18 to be applied retrospectively from January 1, 2027.
• Solvency II amendments and the Insurance Recovery and Resolution Directive (IRRD) to become applicable by January 30, 2027.

Key Dates

Recommendation

ASR Nederland's 2025 results present a mixed picture. While the substantial decline in net profit and negative investment performance are concerning, the company's robust Solvency II ratio, improved operating result, and strategic acquisitions like HumanTouch Holding and the planned Bovemij acquisition signal strong underlying business fundamentals and a clear growth trajectory. The progressive dividend policy and recent S&P rating upgrade further support a stable outlook. Given these offsetting factors, a seasoned investor would likely maintain their position, awaiting further clarity on the realization of integration synergies and a rebound in investment income, while appreciating the company's strong capital position and strategic expansion.

Keywords

ASR Nederland, Aegon, Insurance, Financial Services, SEC Filing, 20-F/A, Annual Report, Solvency II, IFRS, Capital Management, Risk Management, Acquisitions, Dividends, Share Buyback, Underwriting, Market Risk, Liquidity Risk, Operational Risk, Strategic Risk, HumanTouch Holding, Pension Buyouts, Unit-linked, Netherlands